NCT01444417 2017-02-09Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsAmgenPhase 3 Completed62 enrolled 16 charts 1 FDA
NCT00315419 2010-04-21Identifying Characteristics of Bone Marrow Failure SyndromesOffice of Rare Diseases (ORD)Unknown450 enrolled